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CHARACTERIZATION AND DIFFERENTIATION OF PROTEIN 
REABSORPTION GRANULES AND PUNCTATE IGG IN PRIMARY 
PODOCYTOPATHIES 
TOCHUKWU ARTHEA IHEJIRIKA 
ABSTRACT 
 Nephrotic syndrome (NS) is a set of symptoms defined by heavy proteinuria and 
associated with a host of kidney diseases that cause injury to the glomerulus, the filtration 
apparatus of the kidney. Primary podocytopathies (Px), a group of diseases including 
minimal change disease (MCD), primary focal segmental sclerosis (pFSGS), and lupus 
podocytopathy (LP), are the principal cause of idiopathic NS in both children and adults. 
The hallmark feature of Px is the ultrastructural finding of podocyte foot process 
effacement (FPE), so current differential diagnosis of Px relies on technically exhaustive 
electron microscopy (EM) analysis. During routine immunofluorescence (IF) microscopy 
of many Px cases, we have observed punctate IgG (P-IgG) immunoreactivity in the 
glomerulus. P-IgG may represent a disease-specific reactivity that could not only provide 
clues for understanding Px etiology but could also serve as a diagnostic tool. However, 
we have found that P-IgG may be misinterpreted as protein reabsorption granules (PRGs), 
a morphological feature seen in proteinuric conditions. We sought to definitively 
characterize the key characteristics of PRGs and P-IgG in order to differentiate these 
features. To accomplish this, we reviewed prior IF immunostaining of MCD biopsies to 
evaluate anti-human IgG and anti-human albumin staining. We conducted additional IF 
staining on archived MCD biopsies using antibodies against IgG and against the markers 
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of PRGs: albumin, megalin, and cubilin. We found that the P-IgG demonstrates a diffuse, 
global distribution pattern that is specific to glomerular epithelium and is fine and 
scattered. Conversely, the PRGs are coarse, clustered, and frequently demonstrate a focal, 
segmental pattern in the glomeruli and tubules. Co-staining with albumin and megalin 
revealed that the P-IgG and the PRGs do not colocalize in the tissue. While the cubilin 
antibody positively stained the tubular epithelium, it did not stain glomeruli.  
Our results showed that punctate IgG and protein reabsorption granules are 
morphologically and constitutionally distinct and do not colocalize with each other, 
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Nephrotic Syndrome & Podocyte Injury 
 Kidney diseases constitute a major public health concern, both nationally and 
globally. According to the World Health Organization, kidney diseases kill an estimated 
5-10 million people a year1. Global morbidity attributable to kidney diseases is 
tremendous; in 2010 nearly 3 million people worldwide required dialysis, and that 
number was expected to double by 2030. Additionally, the need for transplants far 
outweighs the availability of donor kidneys. Kidney diseases are a major economic 
burden as well; high-income countries often spend more than 3% of their annual 
healthcare-budget on treatment for end-stage renal diseases. For example, United States 
Medicare expenditures totaled over 98 billion dollars for kidney diseases in 2015. These 
diseases are also known to contribute to other major causes of death but are often under-
diagnosed, so the true burden is unknown. While kidney diseases affect all people of all 
backgrounds, people from low-income countries and people with lower socioeconomic 
statuses in high-income countries have a greater risk of poorer outcomes.  Further, those 
of African ancestry may carry genetic mutations in APOL1 that are associated with a 
markedly increased risk of developing chronic kidney disease2.  Boston Medical Center 
(BMC) is the largest safety-net hospital in New England, and the majority of BMC 
patients are from underserved populations, including low-income communities3. In 
accordance with this role, BMC has pledged to provide exceptional care for all. The 
BMC renal medicine department offers services from consultations to end-stage renal 
disease care and has performed hundreds of kidney transplants over the last decade4. 
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Kidney care and research are major components of the institution. Therefore, it is 
essential for the BMC community to advance our understanding of kidney diseases in 
order to uphold our commitment to serving underserved populations. 
 To fulfill this aim of understanding kidney diseases, it is of critical importance to 
recognize their manifestations and the pathologies responsible for them. Nephrotic 
Syndrome (NS) is a frequently encountered cluster of symptoms that results from many 
kidney diseases. NS is characterized by nephrotic range proteinuria (≥3.5 g/day), 
hypoalbuminemia (<25 to 30g/L), hyperlipidemia, and peripheral edema5,6. Heavy 
proteinuria is the hallmark symptom and contributes to subsequent symptoms. NS is most 
often idiopathic, or primary, meaning the result of a kidney-specific disease, such as focal 
segmental glomerulosclerosis.  NS is less often the result of secondary, systematic causes 
such as diabetes or infection6,7.  
The symptoms of NS occur as a result of injury to the glomerulus, the filtration 
apparatus of the kidney (Figure 1)5,6. The glomerulus, or renal corpuscle, is a cluster of 
capillaries contained with a structure known as the Bowman Capsule (BC)5,8,9. The 
glomerular capillary endothelium is fenestrated, allowing for filtration. In contrast to 
other capillaries, which are surrounded by interstitial tissue, these capillaries float within 
the fluid-filled Bowman’s Space. Moreover, the glomerular capillaries are uniquely 
positioned between two resistant vessels - an afferent and efferent arteriole. Due to this 
positioning, the glomerular capillaries are supported by, and work in harmony with, 
specialized structures and cells to perform the critical function of filtering out waste 
products while retaining vital molecules. 
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Of these cells, the podocytes, or visceral epithelial cells are of special 
significance5,8-10. These multitasking cells support the capillaries and are a critical 
component of the filtration barrier. Secondary processes, known as foot processes, project 
from the podocyte cell body and surround the capillaries in an interdigitating pattern. The 
gaps, or filtration slits, between the foot processes are spanned by a thin permeable 
membrane called the slit diaphragm, a structure that is only visible under electron 
microscopy (EM). The filtration slits compose part of the glomerular filtration barrier, 
and function by enabling selective permeability10. When podocytes are injured, they go 
through many morphological changes, the most prominent being foot process effacement 
(FPE) (Figure 2)10-12. FPE is defined as the retraction, widening, and shortening of the 
foot processes, leading to broad, flattened processes and the loss of the interdigitating 
pattern5,12. These changes lead to the derangement of the filtration slits and slit 
diaphragms. Although the underlying mechanism is not fully understood, FPE is 





Figure 1: Structure of Glomerulus. Illustrated depiction of glomerulus with labeled 




Figure 2: Normal and Injured Podocytes. Illustrations of normal (top) and injured 
(bottom) podocytes surrounding glomerular capillary loops. Podocytes and foot processes 
are in blue, the glomerular basement membrane is yellow. Sections labeled “6” depict 










The podocyte injuries responsible for the symptoms of NS are often caused by a 
group of glomerular diseases known as podocytopathies13. These injuries can occur as a 
result of direct or indirect mechanisms.  Primary podocytopathies (Px), like Minimal 
Change Disease (MCD), Primary Focal Segmental Glomerulosclerosis (pFSGS), and the 
newly recognized Lupus Podocytopathy (LP), result from direct insult to the 
podocyte13,14. MCD is one of the major primary diseases causing idiopathic NS, 
accounting for 10-15% of adult patients and 70-90% of juvenile patients with NS over 1 
year of age15. MCD is characterized by an absence of obvious glomerular abnormalities 
when tissue is viewed under light microscopy; the only morphological feature is FPE, 
which may only be discerned when viewed under EM. Focal Segmental 
Glomerulosclerosis (FSGS) is progressive glomerular scarring16. Early in the disease 
process, the scarring is focal (only involving a few glomeruli) and segmental (only 
affecting a portion of the glomerulus). It can progress to diffuse and global glomerular 
involvement. Because there is a diversity of causes as well as lesion morphology, FSGS 
is classified into different variants, including the idiopathic variant pFSGS and the 
adaptive variant secondary FSGS (sFSGS). Like MCD, pFSGS is clinically associated 
with NS and features severe podocyte injury and diffuse FPE. LP is a newly recognized 
entity, with FPE and morphology suggestive of MCD or FSGS in patients with pre-
existing systemic lupus erythematosus, without peripheral immune aggregate deposition 
or endocapillary proliferation14.  
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Unfortunately, the etiologies of Px are still unclear. In the case of MCD, much 
research has suggested an autoimmune basis as the cause of the disease15,17. Rituximab 
and other anti-CD20 therapies have proven to be effective at treating both child and adult 
forms of MCD. CD20 is a transmembrane protein found on B cells, and anti-CD20 
monoclonal antibodies are used to treat B cell proliferative diseases18. The success of 
anti-CD20 therapies points to B cell dysregulation being involved in pathogenesis, 
specifically autoantibody-mediated injury 17.  
 
Challenges in Current Methods for Diagnosing Px 
Diagnosing Px, especially MCD, can be a hurdle. As mentioned earlier, 
differential diagnosis requires EM, a technique used in diagnostic pathology to visualize 
ultrastructural changes in tissue19,20. This is, of course, the biggest advantage of EM; the 
ability to see details at a much higher resolution than light microscopy. While it is a 
useful tool, there are many disadvantages of EM. Biopsies need to be specially processed 
for transmission EM (TEM), the method used most often in diagnostic pathology19. 
Processing and embedding specimens can take several hours, and in our lab, a portion of 
this process is often done overnight. Once the tissue is embedded, semi-thin sections are 
cut using glass knives to survey the tissue prior to ultrathin sectioning with diamond 
knives. These thin sections are placed on small copper grids and stained with the heavy 
metals uranyl acetate and lead citrate. In our lab, this process usually takes a minimum of 
2 days. Following processing, images are taken using via TEM, which uses an electron 
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beam to generate an image. However, due to the nature of electron microscopy, these 
images are always black-and-white and 2-dimensional.  
Processing and staining EM sections is a specialized technique, and training to 
become a skilled technician takes time. Electron microscopes are also expensive and 
large, requiring their own rooms and equipment to operate. They also require special 
servicing. These are significant hurdles for healthcare professionals in resource-poor 
areas to overcome, increasing the gaps in care for people already likely to have poorer 
outcomes20.  
In contrast, immunofluorescence (IF) is a faster and less technically rigorous 
process. In this technique, fluorescent probe-labeled antibodies are used to stain proteins 
of interest on tissues to be viewed21. There are 2 methods of IF staining: direct and 
indirect. With direct staining, the fluorescent tag, or fluorophore, is directly conjugated to 
a primary antibody that targets the antigen of interest. Indirect staining is a 2 or more-step 
process: an unconjugated primary antibody is first used, then a fluorophore-conjugated 
secondary antibody targets the primary. Direct staining is the faster method and is used 
primarily in our clinical lab for routine staining. Indirect staining is more sensitive and 
allows for signal amplification.  
This technique can be done on formalin-fixed paraffin-embedded (FFPE) tissues 
and frozen tissues; our lab uses fresh frozen tissue embedded in Optimum Cutting 
Temperature (OCT) compound for clinical IF. Frozen tissues have the advantage of 
preserving more antigenicity than FFPE tissues, keeping the proteins in a more pristine 
state and allowing for more enhanced visualization under the microscope. Frozen tissues 
 
9 
can be processed, sectioned, stained, and imaged within a day. Tissues are viewed and 
photographed with fluorescence microscopes, which excite the fluorophores and cause 
them to emit light. This method allows for easy visualization of a vast array of molecules 
in virtually any tissue or cell type. Moreover, multiplex staining targeting multiple 
antigens can be done simultaneously on one slide, allowing for colocalization studies. 
Colocalization refers to when multiple fluorophores overlap on the tissue, signaling that 
the antigens are located in the same area22.  IF microscopy requires less specialized skill 
than EM, so training is simpler. Moreover, the equipment and materials needed are less 
expensive, and operating IF microscopes is not much more complicated than operating 
light microscopes. These advantages make IF microscopy a more accessible technique, 
especially for hospitals without access to many resources.  
 
Punctate IgG and Protein Reabsorption 
 Members of our team, as well as colleagues in other institutions, have observed 
and documented a phenomenon that could lead to important advancements in 
understanding Px. Fine, granular, or punctate, IgG (P-IgG) immunoreactivity in the 
glomerular epithelium has been observed during routine frozen IF microscopy of Px 
(Figure 3). This observation could have important etiological and diagnostic implications, 
potentially supporting an autoimmune mechanism of injury. If so, future studies could 
lead to a therapeutic target. Furthermore, this entity could represent a disease-specific 
morphology that could be potentially be used as a biomarker of Px. Because P-IgG are 
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observed during IF studies rather than EM, this finding could be exploited to facilitate 
rapid diagnosis of Px.  
 One obstacle to this possibility is that the P-IgG may be interpreted as protein 
reabsorption, a common finding in proteinuric diseases. As stated above, glomeruli work 
to filter blood. Blood flows through the glomerular capillaries and water and small 
solutes are filtered out5,23. This filtrate then enters the proximal tubules where the tubular 
epithelial cells reabsorb most of the water and salt, leaving waste to be excreted as urine. 
While larger molecules are meant to be retained in the blood, lower molecular weight 
proteins, such as albumin, enter the filtrate in both healthy and diseased states. These 
proteins are also reabsorbed by the tubular epithelial cells. In healthy individuals, 
virtually none of the protein ends up in the urine. However, under proteinuric conditions 
the reabsorption mechanism becomes overwhelmed, leading to the formation of protein 
reabsorption granules (PRGs), or droplets5,24,25. PRGs are clustered granules of varying 
sizes and are found in epithelial cytoplasm5,26. While PRGs are most often seen in the 
tubules, they can also occur in podocytes5,27-30. Albumin is the primary component of 
PRGs; indeed, albumin immunohistochemical staining is performed routinely to indicate 
protein reabsorption5. Immunoglobulins such as IgG and other plasma proteins are other 
components of PRGs26.  
The mechanism of protein reabsorption is not yet fully understood, but the most 
commonly accepted process is receptor-mediated endocytosis (Figure 4)5,23-25,27-31. The 
major players in this pathway are megalin and cubilin, which are multi-ligand receptors 
heavily expressed on the apical surface, or brush border, of the proximal tubular 
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epithelium23,24,27-29,31,32. Proteins bind to either cubilin or megalin, forming a complex that 
is delivered to clathrin-coated pits on the cell surface. This complex is then absorbed into 
the cell in endosomes, where acidification occurs to separate the receptor and protein5,23-
25,30. The protein is then further broken down in lysosomes and the resultant amino acids 
then may be released into the cell or trafficked out. The receptors are released and 
recycled back to the cell surface. Many other proteins are also involved in this process, 
including amnionless, ClC-5, and disabled-2.  
This mechanism is well-documented in the tubules, but protein reabsorption in the 
glomeruli is less understood27-29. Podocytes have been shown to express cubilin, megalin, 
amnionless, ClC-5, and disabled-2 in vitro and in cultured cells29. In vitro experiments 
have suggested that these proteins accomplish the same functions in the podocyte.      
 Because PRGs occur in proteinuric diseases such as the Px, they are likely to 
occur in the same tissues as the P-IgG. Moreover, even though albumin is the main 
component and maker of PRGs, IgG is also a component. Although research conducted at 
our lab and other labs suggests that P-IgG and PRG are the results of 2 separate 
etiologies, others have questioned this hypothesis and interpreted P-IgG as PRGs 17. As 
P-IgG could have important implications for Px research and diagnosis, our lab is very 











Figure 4: Schematic of receptor-mediated endocytosis in the proximal tubules24.  
 
Research Aims 
 P-IgG could represent a disease-specific autoimmunoreactivity and could have an 
important role in elucidating Px etiology, especially in MCD. If so, this finding could 
potentially serve as a biomarker, facilitating rapid diagnosis and subsequent treatment of 
Px. However, their potential role could be missed if they are misinterpreted as PRGs. We 
hypothesized that P-IgG and PRG represent separate entities. We aimed to define the 
morphologic features of both phenomena in order to differentiate them. Additionally, we 
planned to use IF co-staining to determine if PRGs were constitutionally different from 





Biopsy Retrieval and Review 
  This study was approved by the human studies Institutional Review Board at 
BMC. Kidney biopsies, including diagnostic reports, IF and EM images, unstained slides, 
and frozen OCT-embedded tissue blocks, were retrieved from the tissue archives of the 
Departments of Pathology and Laboratory Medicine at BMC. Biopsies retrieved were of 
the following disease types: MCD, sFSGS, thin glomerular basement membrane disease 
(TGBM), lupus nephritis (LN), and collapsing glomerulopathy (CG).  We reviewed the 
biopsy reports to ensure we only included cases with known protein reabsorption. 
 
Antibody Titration 
  Antibody dilution optimization for indirect antibodies was carried out on 
sFSGS, TGBM, LN, and CG tissue. Starting dilutions were based on dilutions found in 











Table 1. Immunofluorescent Antibodies 
 
Target Host Supplier Catalog # Conjugate Dilution Use 
Human 
Albumin 
Rabbit Dako F0117 FITC 1:100 Direct/Tertiary 
Human 
IgG 
Rabbit Dako F0315 FITC 1:20 Direct/Tertiary 
Human 
Albumin 
































  Frozen OCT-embedded tissue was retrieved from the renal pathology archives at 
BMC. Fresh frozen sections were cut at 4 µm via cryostat and placed onto frosted glass 
slides. In some cases, unstained pre-cut frozen slides were utilized. Slides were fixed in 
95% ethanol for 10 minutes and rinsed with 10% phosphate-buffered saline (PBS) before 
blocking. For albumin and cubilin co-staining, tissues were incubated for 1 hour at room 
temperature in 2% or 1% bovine serum albumin (BSA, Sigma), respectively. For megalin 
co-staining, slides were incubated for 10-15 minutes at room temperature in Background 
Buster (Innovex).  Sections were then incubated overnight at 4 °C with the appropriate 
primary antibody (Table 1). After primary incubation, the sections were incubated in 
secondary for 1 hour at room temperature and then in the FITC-conjugated IgG for 45 
minutes at room temperature.  Sections were then mounted on slides with a mounting 
medium (Dako S3023) and examined with the Olympus BX60 epifluorescence 
microscope. 
 
Image Capture and Analysis 
  Digital micrographs were captured using the Infinity Analyze program by 







Protein Reabsorption Granules and Punctate IgG are Morphologically Distinct 
To meet our first aim of differentiating the morphologic characteristics of PRGs 
and P-IgG, we reviewed archived renal biopsies of patients with MCD from BMC. We 
examined IF micrographs taken during routine clinical diagnostic microscopy, 
specifically albumin and IgG stains (Figure 5).  
 First, we found that P-IgG are fine in size and sparsely scattered; PRGs, 
represented by the albumin, are coarse and aggregate in clusters (Table 2). PRGs are 
found in both tubular and glomerular epithelium. P-IgG, on the other hand, are found 
solely in glomerular epithelium. P-IgG immunoreactivity demonstrates a diffuse and 
global distribution; PRGs occur focally and segmentally. Furthermore, when reviewing 
images of other antibody stains, other immunoreactants besides albumin, including IgG, 





Figure 5: Epifluorescence micrograph of MCD kidney biopsy stained with FITC-
conjugated anti-IgG (left) and anti-albumin (right). Arrows depict P-IgG and PRGs, 
respectively. The P-IgG is globally distributed in the glomerular epithelium and has a 
fine, scattered pattern. The PRGs are segmentally distributed in the glomerulus and the 












Table 2. Punctate IgG vs Protein Reabsorption: Morphologic Characteristics. 
Summarized results of P-IgG and PRG morphology comparison. 
 
Characteristic P-IgG PRG 
Location Specific to Glomerular 
Epithelium 
Tubular and Glomerular 
Epithelium 
Distribution Diffuse; Global Focal; Segmental 
Size Fine Coarse 
Aggregation Scattered; often sparse Often Clustered 
Protein Composition IgG Albumin in combination 
with various 
immunoreactants 
(sometimes including IgG) 
 
 
Antibody Work Up 
After reviewing the images, we conducted antibody co-staining to confirm the 
differences we noted and as colocalization studies. We used the direct, FITC-conjugated 
anti-human IgG antibody used in the clinical lab, paired with indirect antibodies against 
albumin, megalin, and cubilin as markers for PRGs. To ensure optimum performance of 
antibodies, we worked up, or optimized, the indirect antibodies. We began by identifying 
antibodies with known protocols and dilutions for frozen-tissue immunofluorescence. We 
reviewed biopsy reports and identified nephrectomies and needle biopsy cases of sFSGS, 
TGBM, LN, and CG with known albumin-positive PRGs. Cases were first stained with 
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varying dilutions of the indirect antibody to find a dilution that was not over- or under-
saturated, and to confirm that the antibody stained expected structures like the PRGs. For 
megalin and cubilin, we also expected to see proximal tubular brush border staining as 
they are both highly expressed there. The albumin antibody positively stained PRGs 
(Figure 6) and the megalin antibody positively stained both the brush border and 
glomerular epithelium (Figure 7). The cubilin did not stain as expected, as we discuss 
below. 
We then conducted co-staining with the IgG antibody to ensure that all antibodies 
used still worked when applied together. For validated antibodies, final co-staining was 






Figure 6: Epifluorescence micrograph of LN kidney biopsy stained with indirect 
albumin antibody. Arrow depicts albumin positive PRG. Image taken at 20X 




Figure 7: Epifluorescence micrograph of nephrectomy biopsy stained with indirect 




Albumin Does Not Colocalize with P-IgG 
We used the direct, FITC-conjugated anti-human IgG antibody used in the clinical 
lab (F0315, Dako) paired with an indirect antibody against albumin (ab2406, Abcam). 
We stained fresh-cut MCD sections in addition to slides that were previously cut and 
stored in a -80℃ freezer.  
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The results of the albumin staining were consistent with the results of the image 
review; the albumin-stained PRGs and the P-IgG had the same characteristics described 
above (Figure 8). We used ImageJ to merge the images of the different immunostains to 
observe colocalization. We found that although IgG could colocalize with PRGs, the 






Figure 8: Epifluorescence micrograph of MCD kidney biopsy co-stained with 
albumin (red) and IgG (green). Merged image in center. Arrows depict PRGs and P-
IgG. IgG was seen to colocalize with albumin in PRGs (orange areas in merged image). 
Albumin did not colocalize with P-IgG. Image taken at 40X magnification. 
 
Megalin Does Not Colocalize with P-IgG 
After the work up process, we co-stained MCD cases with Megalin and IgG 
antibodies. This was done simultaneously with the albumin co-staining, using the same 
MCD biopsies and slides. Images were again captured and merged to observe co-
localization (Figure 9). We found that megalin stained tubular and glomerular epithelium, 
following the same distribution pattern as described in the albumin stains. As in the 
albumin co-staining, megalin and IgG colocalized in the PRGs. However, megalin did 
not colocalize with the P-IgG, and P-IgG occurred in glomeruli in which megalin-








Figure 9: Epifluorescence micrograph of MCD kidney biopsy co-stained with 
megalin (red) and IgG (green). (A): Micrographs prior to merging. (B): Merged image 
with regions enlarged in insets. Arrows in the insets show PRGs and P-IgG. IgG 
colocalizes with megalin in clusters (yellow-orange in image); megalin does not 
colocalize with P-IgG. Image taken at 40X magnification. 
 
Cubilin Antibody Did Not Stain Glomerular PRGs 
We set out to repeat the co-staining experiments with cubilin, the other major 
receptor involved in renal protein reabsorption. We conducted antibody optimization in 
the previously described manner. The cubilin positively stained the tubular brush border, 
as expected, in all the tissues (Figure 10). However, cubilin did not stain any identifiable 
structures in the glomeruli. Nevertheless, we moved on to co-staining MCD cases; we 
again found that the cubilin did not stain any identifiable features in the glomeruli. In one 
MCD case, we observed a strange staining pattern that we could not attribute to any 
structure (Figure 11). To confirm that there were PRGs, we co-stained a CG case with the 
indirect cubilin and a FITC-conjugated direct albumin antibody (Figure 12). Although 





Figure 10: Epifluorescence micrograph of nephrectomy biopsy stained with cubilin. 







Figure 11: Epifluorescence micrograph of MCD kidney biopsy stained with cubilin. 
Cubilin immunoreactivity is visible on the glomerulus. It is unclear what structure it is 








Figure 12: Epifluorescence micrograph of CG kidney biopsy co-stained with 
albumin (green) and cubilin (red). Albumin staining visible throughout the glomerulus; 
however, cubilin is not visible in the glomerulus. Cubilin immunostaining does occur on 































 We were able to define key characteristics of PRG and P-IgG morphology. Our 
characterization showed that the two entities are distinct in appearance, composition, and 
location. Our albumin co-staining studies further confirmed that not only are the PRGs 
and P-IgG visually distinct but that they are also constitutionally distinct. Our 
colocalization studies utilizing albumin and megalin also showed that PRGs do not 
overlap with P-IgG. Taken all together, we conclude that P-IgG and PRGs represent two 
separate phenomena. 
As part of our aims, we planned to stain against the proteins involved in the 
mechanism of protein reabsorption, specifically megalin, cubilin, amnionless, and ClC-5. 
Due to various factors, we were only able to get conclusive results from the megalin 
stain. Because the P-IgG is observed during IF staining of frozen tissue, we specifically 
sought antibodies that we were known to work in that setting. We were unable to find 
antibodies against amnionless and ClC-5 that fit that requirement. Work is ongoing to 
identify the best antibody candidates and optimize protocols for them. This work 
continues to be of particular interest because existing studies on protein reabsorption in 
the glomerulus are lacking. 
Cubilin was included as a target in this study because, like megalin, it is a multi-
ligand receptor involved in the protein endocytosis. Prior to MCD case staining, we 
tested all the non-clinical antibodies used on non-MCD tissue to validate their use. Part of 
this validation required evaluating whether the antibodies of interest stained expected 
structures. The cubilin antibody positively stained the tubular brush border, which was 
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expected because cubilin is highly expressed there. However, even though efforts were 
made to only include cases with known glomerular protein reabsorption, the cubilin never 
stained PRGs within the glomerulus. There was one case with an unusual pattern of 
staining in a glomerulus, but we could not determine what structures were being stained. 
To confirm if the cubilin was staining PRGs in the glomerulus, we performed a 
colocalization study with albumin and cubilin on a CG case. Again, we found that even 
when there were clear instances of PRGs in the glomeruli, the cubilin did not colocalize 
with them. This was unexpected as albumin is believed to have a higher affinity to cubilin 
than to megalin29. Unlike megalin, cubilin has no transmembrane region, so it forms a 
complex with amnionless to translocate to the membrane. The CUBAM complex, as it is 
known, is necessary for cubilin-mediated endocytosis, and it is independent of megalin. 
Although cubilin is known to be expressed on podocytes, almost all glomerular research 
has been done in vitro, on autopsied tissue, or in animal models29. There are still a lot of 
unknowns regarding protein reabsorption, especially in the glomeruli, so this observation 
could have some implications in cubilin-mediated protein reabsorption in podocytes. 
Expanding our study to more disease types and colocalization studies with cubilin and 
amnionless in the glomerular epithelium could shed light on this. 
One of the limitations we faced in this study was the lack of available tissue. 
There are other ongoing studies in our lab evaluating MCD biopsy tissue, and we only 
had access to the BMC renal archive, so we had a finite amount of tissue to work with. 
Samples of the other Px - pFSGS and LP – were also limited for these reasons. 
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Expanding this study to include other medical centers would not only help confirm our 
results but could also help paint a clearer picture of this process. 
This study is part of ongoing work in our lab and in Dr. Astrid Wein’s lab at 
Brigham and Women’s Hospital (BWH) to understand and define P-IgG. Part of this 
research is in understanding what role, if any, P-IgG plays in pathogenesis. The cause of 
Px remains unknown, although immune dysregulation is thought to play a role17. The 
effectiveness of anti-B-cell therapies in treating MCD supports an autoantibody-mediated 
cause17.  Our colleagues at BWH have found circulating autoantibodies targeting nephrin, 
a core component of the slit diaphragm17,33. Nephrin is vital to the maintenance of 
glomerular filtration; animal models have shown that antibody-mediated damage of 
nephrin results in massive proteinuria. The BWH team found that P-IgG colocalizes with 
nephrin, a finding that could have major implications for elucidating the mechanisms of 
these diseases. The findings of the present study support the hypothesis that P-IgG, rather 
than being the result of protein reabsorption, is involved in the pathogenesis of Px.    
In conclusion, our findings demonstrate that P-IgG and PRGs are morphologically 
distinct and may be visually differentiated in routine clinical IF. Moving forward, more 
research can be directed towards using P-IgG as a diagnostic tool and as a therapeutic 
target. Although our original goals focused on differentiating P-IgG from PRGs, our 
unexpected cubilin results led to new questions. Further studies on protein reabsorption in 
the glomeruli are necessary to clarify this finding.  
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